| |
| |
|
| Insider
Information: |
Trizzino John |
| Relationship: |
President and COO |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
27,972 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$10,056 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,972 |
|
|
| Total
Value |
$10,056 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President and COO |
2024-03-10 |
27,972 |
2011-08-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
91 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-05-07 |
4 |
AS |
$176.60 |
$33,559 |
D/D |
(190) |
287 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-06-25 |
4 |
D |
$189.79 |
$76,485 |
D/D |
(403) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO, CBO & Interim CFO |
• – – |
2021-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
834 |
1,121 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-13 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-13 |
4 |
AS |
$231.29 |
$1,764,433 |
D/D |
(7,499) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-14 |
4 |
OE |
$19.08 |
$143,081 |
D/D |
7,499 |
8,217 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-14 |
4 |
AS |
$233.17 |
$1,774,360 |
D/D |
(7,499) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-20 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-20 |
4 |
AS |
$223.18 |
$1,706,748 |
D/D |
(7,500) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-21 |
4 |
AS |
$223.95 |
$1,705,265 |
D/D |
(7,500) |
718 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-21 |
4 |
OE |
$19.08 |
$143,100 |
D/D |
7,500 |
8,218 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,537 |
4,255 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-26 |
4 |
D |
$248.16 |
$424,105 |
D/D |
(1,709) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-27 |
4 |
AS |
$228.69 |
$1,759,833 |
D/D |
(7,501) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-27 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-28 |
4 |
OE |
$19.08 |
$143,119 |
D/D |
7,501 |
10,047 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-09-28 |
4 |
AS |
$203.26 |
$1,574,637 |
D/D |
(7,501) |
2,546 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,600 |
4,146 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2021-12-14 |
4 |
D |
$168.43 |
$130,196 |
D/D |
(773) |
3,373 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-06-25 |
4 |
D |
$51.67 |
$14,364 |
D/D |
(278) |
3,928 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-06-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
833 |
4,206 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-08-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
655 |
4,583 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-08-19 |
4 |
D |
$36.22 |
$11,482 |
D/D |
(317) |
4,266 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-09-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,538 |
7,804 |
0 |
- |
|
| NVAX |
Novavax Inc |
EVP, CCO and CBO |
• – – |
2022-09-26 |
4 |
D |
$18.87 |
$32,249 |
D/D |
(1,709) |
6,095 |
0 |
- |
|
91 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
